Conference Poster
Familial hypercholesterolemia management beyond statins: A clinical case
Méndez-Castillo, M.
|
Carrión, Valery
|
Guerra Méndez, A.
| Fecha de publicación | Revista | DOI |
agosto de 2026 |
Resumen
Background and Aims: Familial hypercholesterolemia (FH) is characterized by markedly elevated LDL-C levels and increased cardiovascular risk. Many patients fail to achieve LDL-C targets with statins or ezetimibe alone and require combination therapy. Bempedoic acid, an oral ATP citrate lyase inhibitor, provides an additional LDL-C lowering option. Evaluating its effectiveness in patients inadequately controlled on standard therapy is essential.